Company intelligence / Profile preview

Ashermed Healthcare Communications

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Asher Med provides a commercial telehealth and practice support platform connecting independent providers with pharmacies and wellness businesses for medical weight loss services based on GLP-1 drugs. It does not own clinical programs or generate clinical results; it only facilitates administrative/coordination services.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Small molecule
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Affiliations with independent licensed providers and 503A compounding pharmacies; no major pharma/biotech partnerships

Beyond the preview

Go deeper on Ashermed Healthcare Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ashermed Healthcare Communications.

Explore the full profile